Continuous murmurs

Continuous Hemofiltration and Hemodialysis

Continuous STsegment monitoring

Esophageal Doppler monitor EDM

Diabetes

2.8 million people in the UK have been diagnosed with diabetes in the UK and a further 850,000 people are undiagnosed. Diabetes is characterized by high blood glucose levels, resulting from a prob...

Medtronic Sentrino continuous glucose monitor wins CE mark

Medtronic has obtained the CE mark approval for its Sentrino continuous glucose monitor (CGM), designed for use in hospital critical care units (CCU).

Dexcom's continuous glucose monitor gets FDA OK

Dexcom has received FDA approval for its Dexcom G4 PLATINUM continuous glucose monitoring system, which includes features suc -More- 

Navigator glucose monitor outperformed others

NEW YORK (Reuters Health) - In type 1 diabetics, the Navigator (Abbott Diabetes Care) continuous glucose monitor is more accurate than the Seven Plus (DexCom) or the Guardian (Medtronic), a new pa...

C8 MediSensor wins CE mark for non-invasive continuous glucose monitor

The European Union has granted CE mark to C8 MediSensors' non-invasive continuous glucose monitor (nCGM), designed for use in patients with diabetes.

[C8 MediSensors] brings in $19mm via Series C-1 preferred stock sale

[C8 MediSensors Inc.], a provider of noninvasive continuous glucose monitoring systems for diabetics, raised $19mm through the sale of preferred C-1 shares to undisclosed returning investors. The mone...

Dexcom receives FDA approval for G4 PLATINUM continuous glucose monitoring system

Dexcom, a leader in continuous glucose monitoring, announced today that the U.S. Food and Drug Administration has approved its eagerly anticipated new continuous glucose monitoring system, the Dexcom...

ADA: Hypo-hyperglycemia minimizer system feasible

(HealthDay) -- The hypoglycemia-hyperglycemia minimizer (HHM) system, which includes a continuous, subcutaneous insulin infusion pump, continuous glucose monitor (CGM), and software, is able to predic...

Positive results from first human clinical trials of a first-generation artificial pancreas system

(Tonic Life Communications) Results from the first feasibility study of an advanced first-generation artificial pancreas system indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System was...

Accuracy of a portable glucose meter and of a Continuous Glucose Monitoring device used at home by patients with type 1 diabetes.

Patients with diabetes are recommended to self-monitor their blood glucose levels also at home. Accuracy of a hand-held glucometer and a Continuous Glucose Monitoring (CGM) device were comparatively e...

The Landmark JDRF Continuous Glucose Monitoring Randomized Trials: a Look Back at the Accumulated Evidence.

Despite improvements for management of type 1 diabetes (T1D), patients have difficulty achieving glycated hemoglobin (A1c) levels recommended by the Diabetes Control and Complications Trial (DCCT). Tw...

Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes.

We evaluated glycaemic variability with continuous glucose monitoring system in 31 people with Type 1 diabetes mellitus using multiple daily injections initially and after switching to continuous subc...

Continuous glucose monitoring reduces both hypoglycaemia and HbA(1c) in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump.

AIM: This study aimed to assess the effectiveness of continuous glucose monitoring (CGM) for glucose control in type 1 diabetic patients treated by continuous subcutaneous insulin infusion (CSII) and...

Data Capture of Transdermal Glucose Monitoring through Computerized Appliance-Based Virtual Remote Sensing and Alert Systems.

Monitoring of blood glucose levels is important to persons with diabetes or pre-diabetic, abnormal glucose indications. Such individuals must determine when insulin is needed to reduce glucose levels...